Astrana Health Stock Market Outlook
| ASTH Stock | 21.10 0.61 2.81% |
Under 51% of Astrana Health's investor base is interested to short. The analysis of overall sentiment of trading Astrana Health stock suggests that many investors are impartial at this time. Astrana Health's investing sentiment shows overall attitude of investors towards Astrana Health.
Comfort Level 49
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Astrana Health's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Astrana Health.
News SentimentBullish | Hype SentimentBearish | Insider SentimentAcquiring |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Astrana Health is 'Strong Sell'. The recommendation algorithm takes into account all of Astrana Health's available fundamental, technical, and predictive indicators you will find on this site.
Execute Astrana Health Advice
The Astrana recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Astrana Health. Macroaxis does not own or have any residual interests in Astrana Health or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Astrana Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weakest | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Tiny | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
For the selected time horizon Astrana Health has a Mean Deviation of 3.31, Standard Deviation of 5.34 and Variance of 28.48Our investment recommendation module complements current analysts and expert consensus on Astrana Health. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Astrana Health is not overpriced, please confirm all Astrana Health fundamentals, including its cash flow from operations, and the relationship between the gross profit and beta . Given that Astrana Health has a shares owned by institutions of 54.80 %, we suggest you to validate Astrana Health market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Astrana Health Trading Alerts and Improvement Suggestions
| Astrana Health generated a negative expected return over the last 90 days | |
| Astrana Health has high historical volatility and very poor performance | |
| Astrana Health is unlikely to experience financial distress in the next 2 years | |
| About 22.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Astrana Health Buy, Sell, or Hold Post Q3 Earnings |
Astrana Health Returns Distribution Density
The distribution of Astrana Health's historical returns is an attempt to chart the uncertainty of Astrana Health's future price movements. The chart of the probability distribution of Astrana Health daily returns describes the distribution of returns around its average expected value. We use Astrana Health price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Astrana Health returns is essential to provide solid investment analysis for Astrana Health.
| Mean Return | -0.52 | Value At Risk | -7.67 | Potential Upside | 6.14 | Standard Deviation | 5.34 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Astrana Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Astrana Stock Institutional Investors
| Shares | Northern Trust Corp | 2025-06-30 | 434.5 K | Jacobs Levy Equity Management, Inc. | 2025-06-30 | 420.1 K | Royal Bank Of Canada | 2025-06-30 | 317.1 K | Royce & Associates, Lp | 2025-06-30 | 307.5 K | Hotchkis & Wiley Capital Management Llc | 2025-06-30 | 292.4 K | Diamond Hill Capital Management Inc | 2025-06-30 | 271.5 K | Bank Of New York Mellon Corp | 2025-06-30 | 251.9 K | Amvescap Plc. | 2025-06-30 | 240.2 K | Principal Financial Group Inc | 2025-06-30 | 222.4 K | Blackrock Inc | 2025-06-30 | 6 M | Vanguard Group Inc | 2025-06-30 | 4.8 M |
Astrana Health Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | 39.1M | 54.9M | 6.1M | (5.1M) | (5.8M) | (5.5M) | |
| Free Cash Flow | 51.1M | 59.2M | 39.7M | 44.2M | 50.8M | 53.3M | |
| Other Non Cash Items | 22.9M | 15.2M | 6.4M | 7.7M | 8.8M | 9.6M | |
| Capital Expenditures | 19.2M | 22.9M | 28.5M | 8.0M | 9.2M | 9.7M | |
| Net Income | 49.3M | 50.5M | 57.8M | 49.9M | 57.4M | 60.3M | |
| End Period Cash Flow | 233.1M | 288.0M | 294.2M | 289.1M | 332.5M | 349.1M | |
| Change To Inventory | (5.8M) | 1.0M | 31.4M | 12.2M | 14.0M | 14.7M | |
| Depreciation | 17.5M | 17.5M | 17.7M | 27.9M | 32.1M | 33.7M | |
| Investments | 32.4M | 34.3M | (65.5M) | (192.4M) | (173.2M) | (164.5M) | |
| Change Receivables | (5.8M) | 15.6M | (26.8M) | (28.8M) | (25.9M) | (24.6M) | |
| Net Borrowings | (58.0M) | (828K) | 79.2M | 152.7M | 175.6M | 184.4M | |
| Dividends Paid | 31.1M | 14.0M | 62.1M | 4.0M | 4.6M | 4.4M | |
| Change To Netincome | 2.3M | (106.7M) | (2.0M) | (3.7M) | (3.3M) | (3.5M) |
Astrana Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Astrana Health or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Astrana Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Astrana stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.7 | |
β | Beta against Dow Jones | 2.11 | |
σ | Overall volatility | 4.31 | |
Ir | Information ratio | -0.11 |
Astrana Health Volatility Alert
Astrana Health exhibits very low volatility with skewness of -2.07 and kurtosis of 7.51. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Astrana Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Astrana Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Astrana Health Fundamentals Vs Peers
Comparing Astrana Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Astrana Health's direct or indirect competition across all of the common fundamentals between Astrana Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as Astrana Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Astrana Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing Astrana Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Astrana Health to competition |
| Fundamentals | Astrana Health | Peer Average |
| Return On Equity | 0.0183 | -0.31 |
| Return On Asset | 0.0288 | -0.14 |
| Profit Margin | 0 % | (1.27) % |
| Operating Margin | 0.03 % | (5.51) % |
| Current Valuation | 1.68 B | 16.62 B |
| Shares Outstanding | 50.16 M | 571.82 M |
| Shares Owned By Insiders | 22.16 % | 10.09 % |
| Shares Owned By Institutions | 54.80 % | 39.21 % |
| Number Of Shares Shorted | 2.56 M | 4.71 M |
| Price To Book | 1.36 X | 9.51 X |
| Price To Sales | 0.37 X | 11.42 X |
| Revenue | 2.03 B | 9.43 B |
| Gross Profit | 296.97 M | 27.38 B |
| EBITDA | 141.84 M | 3.9 B |
| Net Income | 49.93 M | 570.98 M |
| Total Debt | 471.84 M | 5.32 B |
| Book Value Per Share | 15.70 X | 1.93 K |
| Cash Flow From Operations | 52.2 M | 971.22 M |
| Short Ratio | 4.85 X | 4.00 X |
| Earnings Per Share | 0.19 X | 3.12 X |
| Target Price | 35.89 | |
| Number Of Employees | 1.9 K | 18.84 K |
| Beta | 0.89 | -0.15 |
| Market Capitalization | 1.06 B | 19.03 B |
| Total Asset | 1.35 B | 29.47 B |
| Retained Earnings | 286.28 M | 9.33 B |
| Working Capital | 272.89 M | 1.48 B |
| Net Asset | 1.35 B |
Note: Disposition of 10759 shares by Kumar Dinesh M. of Astrana Health at 27.16 subject to Rule 16b-3 [view details]
Astrana Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Astrana . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Astrana Health Target Price Consensus
Astrana target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Astrana Health's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 12 | Strong Buy |
Most Astrana analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Astrana stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Astrana Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAstrana Health Target Price Projection
Astrana Health's current and average target prices are 21.10 and 35.89, respectively. The current price of Astrana Health is the price at which Astrana Health is currently trading. On the other hand, Astrana Health's target price is what analysts think the stock is worth. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Astrana Health Market Quote on 9th of February 2026
Target Price
Analyst Consensus On Astrana Health Target Price
Astrana Health Analyst Ratings
Astrana Health's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Astrana Health stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Astrana Health's financials, market performance, and future outlook by experienced professionals. Astrana Health's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
About Astrana Health Buy or Sell Advice
When is the right time to buy or sell Astrana Health? Buying financial instruments such as Astrana Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Astrana Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Diversified Assets Thematic Idea Now
Diversified Assets
Pablicly traded close-end funds and other entities backed by different types of diversified investments. The Diversified Assets theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Diversified Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Astrana Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth 0.997 | Return On Assets |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.